Medical Condition News

RSS

Paddling through mental health: Long-term benefits of SUP revealed in "Freedom on Water" study

A study in the journal Healthcare highlights the significant long-term benefits of stand-up paddling (SUP) on mental health and well-being for individuals with mental disorders, as seen in the "Freedom on Water" project.

14 May 2024

St. Jude researchers unveil mechanisms to block PXR and enhance drug potency

Deaths from cancer or infections can occur when available treatments are ineffective. Once turned on, pregnane X receptor (PXR) activates the expression of genes encoding enzymes that metabolize external chemicals, including drugs.

14 May 2024

Innovative 'mini-brains' could revolutionize Alzheimer's diagnosis and treatment

Using an innovative new method, a University of Saskatchewan (USask) researcher is building tiny pseudo-organs from stem cells to help diagnose and treat Alzheimer's.

14 May 2024

New technique reveals brain cells age at different rates

Engineers at the University of California San Diego have discovered that some brain cells age more rapidly than others, and they are disproportionately abundant in individuals afflicted with Alzheimer's disease.

14 May 2024

Study proposes a novel therapeutic avenue for tackling EHF-induced cholangiocarcinogenesis

This study is led by Dr. Yiming Luo (Hepatic Surgery Centre, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology) and Professor. Huifang Liang (Hepatic Surgery Centre, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology).

14 May 2024

Researchers find beneficial effects of a novel drug in the management of myocardial infarction

Researchers from the Cardiac Regeneration and Heart Failure Research Group (ICREC) at the Germans Trias i Pujol Research Institute (IGTP) and the Heart Institute of the Germans Trias Hospital(iCor) have found beneficial effects of the novel drug Sacubitril/Valsartan in the management of myocardial infarction (MI).

14 May 2024

Pharmacological treatment reduces specific crimes in adolescents with ADHD

A study in the Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP), published by Elsevier, found that pharmacological treatment of attention-deficit/hyperactivity disorder (ADHD) reduced violence- and public-order related crimes.

14 May 2024

New risk assessment tool developed for predicting outcomes in heart failure patients

UVA Health researchers have developed a powerful new risk assessment tool for predicting outcomes in heart failure patients. The researchers have made the tool publicly available for free to clinicians.

14 May 2024

Human cell-based model of thoracic aortic aneurysm offers new opportunities for drug development

Using human cells in laboratory rats, Michigan Medicine researchers have developed a functional model of thoracic aortic aneurysm, creating opportunities for more effective understanding of disease development and treatments for the potentially fatal condition, a study suggests.

14 May 2024

Racial and ethnic disparities in Alzheimer's diagnosis and CNS drug prescription

Compared to Black and Asian people, white and Hispanic people with Alzheimer's disease and related dementias were most likely to be diagnosed with symptoms like depression and agitation, according to a new study from the USC Schaeffer Center for Health Policy & Economics.

14 May 2024

Experts advocate for terminology change in brain injury research

A new editorial published this May in the British Journal of Sports Medicine by experts from Spaulding Rehabilitation, Boston University, Mayo Clinic, and the Concussion Legacy Foundation, argues that the term "subconcussion" is a dangerous misnomer that should be retired.

14 May 2024

Investigational drug shows promise in increasing oxygen uptake for patients with heart condition

People with a common heart condition were able to use significantly more oxygen while exercising after taking an investigational drug in an international clinical trial, according to a study published today in the New England Journal of Medicine.

14 May 2024

New joint guideline highlights importance of coordinated care for peripheral artery disease

Timely diagnosis and proper management of peripheral artery disease (PAD), including coordinated care from a multispecialty team, are essential to help prevent amputation and other cardiovascular complications and to allow patients with PAD to live longer lives with better physical function and improved quality of life, according to a new joint guideline published today in the American Heart Association's flagship, peer-reviewed journal Circulation and simultaneously in the Journal of the American College of Cardiology.

14 May 2024

Study links higher-potency cannabis use in youth to increased risk of psychotic experiences

Young individuals consuming higher-potency cannabis, such as skunk, between ages 16 and 18, are twice as likely to have psychotic experiences from age 19 to 24 compared to those using lower-potency cannabis.

14 May 2024

New study sheds light on interferon combinations' role in lupus variability

In a new study, researchers from Johns Hopkins Medicine say they have uncovered insights as to why lupus symptoms and severity present differently in individuals with the autoimmune condition, which affects up to 1.5 million Americans.

14 May 2024

Sustainable weight loss with personalized semaglutide dosing

New research being presented at the European Congress on Obesity (ECO) in Venice, Italy (12-15 May) has explored the benefits of giving personalised doses of semaglutide to patients taking part in a weight loss programme and tapering them off the medication when they reach their target weight.

14 May 2024

Medical Condition News

Paddling through mental health: Long-term benefits of SUP revealed in "Freedom on Water" study

St. Jude researchers unveil mechanisms to block PXR and enhance drug potency

Innovative 'mini-brains' could revolutionize Alzheimer's diagnosis and treatment

New technique reveals brain cells age at different rates

Study proposes a novel therapeutic avenue for tackling EHF-induced cholangiocarcinogenesis

Researchers find beneficial effects of a novel drug in the management of myocardial infarction

Pharmacological treatment reduces specific crimes in adolescents with ADHD

New risk assessment tool developed for predicting outcomes in heart failure patients

Human cell-based model of thoracic aortic aneurysm offers new opportunities for drug development

Racial and ethnic disparities in Alzheimer's diagnosis and CNS drug prescription

Experts advocate for terminology change in brain injury research

Investigational drug shows promise in increasing oxygen uptake for patients with heart condition

New joint guideline highlights importance of coordinated care for peripheral artery disease

Study links higher-potency cannabis use in youth to increased risk of psychotic experiences

New study sheds light on interferon combinations' role in lupus variability

Sustainable weight loss with personalized semaglutide dosing

Understanding body dysmorphia through WhatsApp profiles of individuals with obesity

Unraveling the genetic connection between IBD and Parkinson's disease

Study sheds light on the crucial role of glutamate tRNA fragments in brain aging and Alzheimer's disease

Curcuminoid compounds show promise against COVID-19 in neuronal cells

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News